Purchases and Sales Made in Q4 2022 in Outlook Therapeutics, Inc. (OTLK)
This table provides information about the institutional ownership of Outlook Therapeutics, Inc. (OTLK) during Q4 2022. The information is specifically focused on institutions that hold shares of Outlook Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 13, 2023
Q4 2022
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-30.1K- 3.09% |
$26.2K - $40.1K
|
946K
$2.03M
|
|
|
Feb 10, 2023
Q4 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-34.5K- 81.9% |
$30K - $45.9K
|
7.62K
$16.4K
|
|
|
Feb 09, 2023
Q4 2022
|
Vista Finance, LLC
|
SELL
|
- |
-120K- 30.17% |
$104K - $160K
|
278K
$597K
|
|
|
Feb 14, 2023
Q4 2022
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-147K- 74.71% |
$128K - $195K
|
49.7K
$107K
|